Impact of Adiposity Measures on Heart Disease Risk Alike

Article

Body mass index (BMI), waist circumference, and waist-to-hip ratio all have a similar strength of association with cardiovascular disease, but do not significantly improve risk prediction when information on blood pressure, diabetes, and lipid levels is available, according to a study published online March 11 in The Lancet.

FRIDAY, March 11 (HealthDay News) -- Body mass index (BMI), waist circumference, and waist-to-hip ratio all have a similar strength of association with cardiovascular disease, but do not significantly improve risk prediction when information on blood pressure, diabetes, and lipid levels is available, according to a study published online March 11 in The Lancet.

David Wormser, of the University of Cambridge in the United Kingdom, and colleagues from the Emerging Risk Factors Collaboration, a consortium of 200 scientists from 17 countries, investigated the association of adiposity measures (BMI, waist circumference, and waist-to-hip ratio) with the risk of first-onset cardiovascular disease. Individual records from 58 cohorts, totaling 221,934 people, were studied to calculate hazard ratios (HRs) per one standard deviation increase in adiposity values.

The researchers found that, in people with BMI 20 kg/m² or higher, the risk of a cardiovascular event was increased (HRs, 1.23 with BMI, 1.27 with waist circumference, and 1.25 with waist-to-hip ratio) after adjusting for age, gender, and smoking status. After adjustment for risk factors, including systolic blood pressure, history of diabetes, and lipid levels, HRs were 1.07 with BMI, 1.10 with waist circumference, and 1.12 with waist-to-hip ratio. Adding information about these three measures in a risk prediction model using conventional cardiovascular disease risk factors had minimal impact on its accuracy.

"BMI, waist circumference, and waist-to-hip ratio, whether assessed singly or in combination, do not importantly improve cardiovascular disease risk prediction in people in developed countries when additional information is available for systolic blood pressure, history of diabetes, and lipids," the authors write.

Several authors disclosed financial ties with the pharmaceutical industry.

Related Content

Newsletter

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Recent Videos
Zachary Wagner, PhD, discusses the harms of bias in reproductive care | Image Credit: ornsife.usc.edu.
Ciera Kirkpatrick, PhD, shows how TikTok is transforming cervical cancer awareness | Image Credit: linkedin.com.
Maria Gallo, PhD, discusses high attendance at crisis pregnancy centers | Image Credit: © x.com.
Eran Bornstein, MD, highlights early signs of preeclampsia clinicians need to know | Image Credit: northwell.edu.
Eran Bornstein, MD explains the need for first trimester preeclampsia screening | Image Credit: northwell.edu.
Veerle Bergink, MD, PhD, highlights familial links of postpartum psychosis | Image Credit: profiles.mountsinai.org.
Related Content
© 2025 MJH Life Sciences

All rights reserved.